Grant of Options

RNS Number : 3920M

Futura Medical PLC

17 September 2012

 



For immediate release

17 September 2012

Futura Medical plc

("Futura" or "the Company")

Grant of Options

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that today it granted options over a total of 550,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.

Director	Number of options granted	Exercise price	Exercise period	Total number of options held following notification	Total number of ordinary shares held
J H Barder	250,000	61.50p	1 Oct 2014 - 30 Sep 2019	750,000	975,330
D B Davies	200,000	61.50p	1 Oct 2014 - 30 Sep 2019	600,000	751,306
D A Martin	100,000	61.50p	1 Oct 2014 - 30 Sep 2019	559,279	280,000

All options were granted under the Futura Medical plc Enterprise Management Incentive Scheme.

The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

MSCLIFVDADIDLIF